Arcturus Therapeutics Holdings Inc. Stock News

Singapore scientists testing a COVID-19 vaccine from U.S. firm Arcturus Therapeutics plan to start human trials in August after promising initial responses in mice.

More than 100 vaccines are being developed globally, including several already in human trials from the likes of AstraZeneca and Pfizer, to try and control a disease that has infected more than 8 mill

Testing using vaccine from US firm Arcturus Therapeutics is set to start in August.

Singapore scientists testing a COVID-19 vaccine from U.S. firm Arcturus Therapeutics plan to start human trials in August after promising initial responses in mice.

Singapore scientists testing a COVID-19 vaccine from U.S. firm Arcturus Therapeutics plan to start human trials in August after promising initial responses in mice.

"The most optimistic case is that it's about this time next year, that we will have a vaccine," Ooi said. Ooi is also working on a monoclonal antibody treatment for COVID-19 and will begin safety tri

Arcturus Therapeutics (NASDAQ:ARCT) was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating in a research report issued on Tuesday, BidAskClub reports. Other research ana

Singapore scientists to start human trials of COVID-19 vaccine in August

In their intervention application, the nurses' union sought formulation of a national Covid-19 management protocol for addressing the serious concerns relating to imminent and extreme risks to workers

The

A partir desta segunda-feira (15), uma equipe de suporte estar

Markt Overzicht door Beursbox.nl (Tom Lassing) over: Dow Jones Industrial Average, Unilever NV. Lees Beursbox.nl (Tom Lassing)'s Markt Overzicht op Investing.com.

Adam Gilchrist gave a shout-out to Indian nurse Sharon Varghese, who has been working in Wollongong as a care-worker.

SAN DIEGO, June 11, 2020 -- Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on.

European stocks slumped Thursday in early trade, losing ground for a fourth session as traders looked for a new catalyst after the breathtaking rally from...